Yoshitaka Honma, Nobuya Monden, Keisuke Yamazaki, Satoshi Kano, Hironaga Satake, Shigenori Kadowaki, Yoshitaka Utsumi, Tomohiko Nakatogawa, Ryo Takano, Koji Fujii, et al. Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU. Clinical Cancer Research. 2024. OF1-OF12
Tsutomu Namikawa, Tomoki Tanaka, Masato Utsunomiya, Keiichiro Yokota, Masaya Munekage, Hiromichi Maeda, Hiroyuki Kitagawa, Yusuke Kurioka, Hironaga Satake, Michiya Kobayashi, et al. Gastric cancer with Fanconi anemia in adolescent and young adult patient diagnosed by comprehensive genome profiling using next-generation sequencing. Clinical journal of gastroenterology. 2023
Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, Hiroya Taniguchi, Hideaki Bando, Manabu Shiozawa, Tomohiro Nishina, Hisateru Yasui, Yoshinori Kagawa, Naoki Takahashi, et al. Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit study. Cancer medicine. 2023
Tsutomu Namikawa, Keiichiro Yokota, Hiromichi Maeda, Hiroyuki Kitagawa, Masaya Tamura, Hironaga Satake, Takeki Sugimoto, Michiya Kobayashi, Kazuhiro Hanazaki, Satoru Seo. Gastric and Bone Metastases Arising from Invasive Lobular Carcinoma With Ductal Carcinoma Occurring in one Breast Synchronously. Anticancer research. 2023. 43. 8. 3701-3707
Kei Muro, Kohei Shitara, Kensei Yamaguchi, Takaki Yoshikawa, Hironaga Satake, Hiroki Hara, Naotoshi Sugimoto, Nozomu Machida, Masahiro Goto, Hisato Kawakami, et al. Efficacy of Pembrolizumab Monotherapy in Japanese Patients with Advanced Gastric or Gastroesophageal Junction Cancer. Journal of gastrointestinal cancer. 2023
Yoshinori Kagawa, Daisuke Kotani, Hideaki Bando, Naoki Takahashi, Tetsuya Hamaguchi, Akiyoshi Kanazawa, Takeshi Kato, Koji Ando, Hironaga Satake, Eiji Shinozaki, et al. Plasma RAS dynamics and anti-EGFR rechallenge efficacy in patients with RAS/BRAF wild-type metastatic colorectal cancer: REMARRY and PURSUIT trials. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 16
Hideaki Bando, Daisuke Kotani, Masahito Kotaka, Akihito Kawazoe, Toshiki Masuishi, Hironaga Satake, Hiroya Taniguchi, Kentaro Yamazaki, Takeharu Yamanaka, Eiji Oki, et al. Quadruplet regimen with capecitabine, irinotecan, oxaliplatin, and bevacizumab in chemo-naive patients with metastatic colorectal cancer: Results from the safety lead-in of QUATTRO-II study. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 3
Katsuya Ohta, Takeshi Kato, Masahiro Goto, Tetsuji Terazawa, Shingo Noura, Hironaga Satake, Yoshinori Kagawa, Hisato Kawakami, Hiroko Hasegawa, Kazuhiro Yanagihara, et al. Phase II study of panitumumab monotherapy in chemotherapy-naive frail or elderly patients with unresectable, RAS wild-type colorectal cancer: OGSG 1602. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 4
Masato Nakamura, Hironaga Satake, Koji Oba, Masahito Kotaka, Yoshinori Kagawa, Hisateru Yasui, Takanori Watanabe, Toshihiko Matsumoto, Takayuki Kii, Tetsuji Terazawa, et al. Final results of multicenter phase Ib/ II study of biweekly trifluridine/tipiracil with bevacizumab combination for patients with mCRC refractory to standard therapies (BiTS study). JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 4
